Evidence Repository
The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
Link to SEPIO compliant JSON-LD document
  • No ClinVar Id was directly found from the curated document

CA1244148

Gene: MYOC
Condition: primary open angle glaucoma
Inheritance Mode: Autosomal dominant inheritance
Link to MONDO
UUID: dc4619f5-2785-45f7-8c0d-02455cf12ed5

HGVS expressions

NM_000261.2:c.816A>T
NC_000001.11:g.171636624T>A
CM000663.2:g.171636624T>A
NC_000001.10:g.171605764T>A
CM000663.1:g.171605764T>A
NC_000001.9:g.169872387T>A
NG_008859.1:g.21010A>T
ENST00000037502.11:c.816A>T
ENST00000637303.1:c.235-2006T>A
ENST00000638471.1:c.*154A>T
ENST00000037502.10:c.816A>T
ENST00000614688.1:c.816A>T
NM_000261.1:c.816A>T

Uncertain Significance

Not Met criteria codes 15
PM5 PM4 PS2 PS1 PS3 PS4 PM6 PM2 BA1 BP7 BP4 BS3 BS1 PP1 PP3

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Glaucoma Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 1.1

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Glaucoma VCEP
The c.816A>T variant in MYOC is a synonymous variant (p.Arg272=). The highest minor allele frequency of this variant was in the South Asian population of gnomAD (v2.1.1) = 0.0002941 (9 alleles out of 30,604), which did not meet the PM2_Supporting allele frequency threshold (≤ 0.0001) or the BS1 allele frequency threshold (≥ 0.001). Although this synonymous variant was not predicted to affect splicing, as assessed with SpliceAI (≤ 0.2), it had a CADD score (v1.6) = 11.14, which did not meet the ≤ 10 threshold for BP4 and a GERP score = 3.46 (threshold <0), not meeting BP7 and indicating conservation at this site. There was no functional evidence predicting a damaging or benign impact of this variant on MYOC function. Although a proband with primary open angle glaucoma had been reported carrying this variant, PM2_Supporting was not met, therefore PS4 did not apply. In summary, this variant did not meet any criteria, receiving a score of 0 and a classification as a variant of uncertain significance (uncertain significance classification range -1 to 5) for primary open angle glaucoma based on the ACMG/AMP criteria met, as specified by the ClinGen Glaucoma VCEP (v1, 12 Oct 2021): none.
Not Met criteria codes
PM5
This is not a missense variant.
PM4
This variant does not cause a protein length change.
PS2
This variant has not been identified de novo.
PS1
This variant does not involve an amino acid change.
PS3
No functional evidence has been found for this variant.
PS4
Although a proband with POAG had been reported carrying this variant, PM2_Supporting was not met, therefore PS4 did not apply.
PM6
This variant has not been identified de novo.
PM2
The highest minor allele frequency of this variant was in the South Asian population of gnomAD (v2.1.1) = 0.0002941 (9 alleles out of 30,604), which did not meet the ≤ 0.0001 threshold set for PM2_Supporting.
BA1
This variant did not meet the ≥ 0.01 minor allele frequency threshold in gnomAD (v2.1.1).
BP7
Although this synonymous variant was not predicted to affect splicing, as assessed with SpliceAI (≤ 0.2), it had a GERP score = 3.46 (threshold <0), indicating conservation at this site.
BP4
Although this synonymous variant was not predicted to affect splicing, as assessed with SpliceAI (≤ 0.2), it had a CADD score (v1.6) = 11.14, which does not meet the ≤ 10 threshold for BP4.
BS3
No functional evidence has been found for this variant.
BS1
The highest minor allele frequency of this variant was in the South Asian population of gnomAD (v2.1.1) = 0.0002941 (9 alleles out of 30,604), which did not meet the ≥ 0.001 threshold set for BS1.
PP1
No segregations have been reported for this variant.
PP3
This is not a missense variant.
Approved on: 2023-07-05
Published on: 2023-07-05
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.